AAAAAA

   
Results: 1-14 |
Results: 14
Performance improvement of gated silicon field emitters with a thin layer of boron nitride
Authors: Busta, H Furst, D Pryor, R Li, LH
Citation: H. Busta et al., Performance improvement of gated silicon field emitters with a thin layer of boron nitride, J VAC SCI B, 19(3), 2001, pp. 907-911
A MEMS shield structure for controlling pull-in forces and obtaining increased pull-in voltages
Authors: Busta, H Amantea, R Furst, D Chen, JM Turowski, M Mueller, C
Citation: H. Busta et al., A MEMS shield structure for controlling pull-in forces and obtaining increased pull-in voltages, J MICROM M, 11(6), 2001, pp. 720-725
A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis
Authors: Lipani, JA Strand, V Johnson, K Woodworth, T Furst, D Singh, G Day, R Brooks, P
Citation: Ja. Lipani et al., A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis, J RHEUMATOL, 28(5), 2001, pp. 1170-1173
Networks of regional actors between commitments and options
Authors: Furst, D Schubert, H
Citation: D. Furst et H. Schubert, Networks of regional actors between commitments and options, GEOGR Z, 89(1), 2001, pp. 32-51
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate
Authors: Cohen, S Cannon, GW Schiff, M Weaver, A Fox, R Olsen, N Furst, D Sharp, J Moreland, L Caldwell, J Kaine, J Strand, V
Citation: S. Cohen et al., Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate, ARTH RHEUM, 44(9), 2001, pp. 1984-1992
Low-voltage electron emission from "tipless" field emitter arrays
Authors: Busta, H Furst, D Rakhimov, AT Samorodov, VA Seleznev, BV Suetin, NV Silzars, A
Citation: H. Busta et al., Low-voltage electron emission from "tipless" field emitter arrays, APPL PHYS L, 78(22), 2001, pp. 3418-3420
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
Authors: Binks, M Passweg, JR Furst, D McSweeney, P Sullivan, K Besenthal, C Finke, J Peter, HH van Laar, J Breedveld, FC Fibbe, VE Farge, D Gluckman, E Locatelli, F Martini, A van den Hoogen, F van de Putte, L Schattenberg, AVN Arnold, R Bacon, PA Emery, P Espigado, I Hertenstein, B Hiepe, F Kashyap, A Kotter, I Marmont, A Martinez, A Pascual, MJ Gratwohl, A Prentice, HG Black, C Tyndall, A
Citation: M. Binks et al., Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease, ANN RHEUM D, 60(6), 2001, pp. 577-584
A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis
Authors: Lipani, JA Strand, V Woodworth, T Furst, D Singh, G Johnson, K Day, R Brooks, P
Citation: Ja. Lipani et al., A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis, J RHEUMATOL, 27(4), 2000, pp. 827-830
A pilot study using a staph protein A column (Prosorba (R)) to treat refractory rheumatoid arthritis
Authors: Caldwell, J Gendreau, RM Furst, D
Citation: J. Caldwell et al., A pilot study using a staph protein A column (Prosorba (R)) to treat refractory rheumatoid arthritis, J RHEUMATOL, 26(8), 1999, pp. 1657-1662
Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: Consensus on a preliminary core set of outcome domains
Authors: Smolen, JS Strand, V Cardiel, M Edworthy, S Furst, D Gladman, D Gordon, C Isenberg, DA Klippel, JH Petri, M Simon, L Tugwell, P Wolfe, F
Citation: Js. Smolen et al., Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: Consensus on a preliminary core set of outcome domains, J RHEUMATOL, 26(2), 1999, pp. 504-507
Reviews of physiology, biochemistry and pharmacology - Preface
Authors: Furst, D Pette, D
Citation: D. Furst et D. Pette, Reviews of physiology, biochemistry and pharmacology - Preface, REV PHYS B, 138, 1999, pp. V-VIII
Autologous haematopoietic stem cell transplants for autoimmune disease - feasibility and transplant-related mortality
Authors: Tyndall, A Fassas, A Passweg, J de Elvira, CR Attal, M Brooks, P Black, C Durez, P Finke, J Forman, S Fouillard, L Furst, D Holmes, JA Joske, D Jouet, JP Kotter, I Locatelli, F Prentice, HG Marmont, AM McSweeney, P Musso, M Peter, HH Snowden, JA Sullivan, K Tichelli, A Vavriec, J Wulffraat, NM Schmitz, N Gratwohl, A
Citation: A. Tyndall et al., Autologous haematopoietic stem cell transplants for autoimmune disease - feasibility and transplant-related mortality, BONE MAR TR, 24(7), 1999, pp. 729-734
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
Authors: Maini, R St Clair, EW Breedveld, F Furst, D Kalden, J Weisman, M Smolen, J Emery, P Harriman, G Feldmann, M Lipsky, P
Citation: R. Maini et al., Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial, LANCET, 354(9194), 1999, pp. 1932-1939
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate
Authors: Strand, V Cohen, S Schiff, M Weaver, A Fleischmann, R Cannon, G Fox, R Moreland, L Olsen, N Furst, D Caldwell, J Kaine, J Sharp, J Hurley, F Loew-Friedrich, I
Citation: V. Strand et al., Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate, ARCH IN MED, 159(21), 1999, pp. 2542-2550
Risultati: 1-14 |